Target
Cadherin-3 (CDH3)
3 abstracts
Abstract
BC3195, a novel ADC targeting CDH3: Preliminary results of a first-in-human phase I study in patients with advanced solid malignancies.Org: Guangdong Lung Cancer Institute, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Biocity Biopharmaceutics, Shanghai, China, Gracell Biotechnologies, Ltd.,
Abstract
Proteomic profiling of FOLFOX-resistant colorectal cancer cells.Org: Department of Health Technology and Informatics, Faculty of Health and Social Sciences, The Hong Kong Polytechnic University,
Abstract
Comorbidities in patients with sarcoma: Insights from the National In-Patient Database from 2006 to 2014.Org: John H. Stroger, Jr. Hospital of Cook County, Chicago, IL,